Porcine bocavirus (PBoV), a newly identified parvovirus in the family Parvoviridae, has been reported worldwide in swine with post-weaning multisystemic wasting syndrome, respiratory disease or diarrhoea and in asymptomatic swine. NP1 is a protein unique to the genus Bocavirus and its function is not fully understood. In this study, we show that the N-terminal region of PBoV NP1 contains two classical nuclear localization signals (cNLSs) and a non-classical NLS. The N-terminal region also inhibits the promoter activity of IFN-b and IFN-stimulated response element activity the same as full-length NP1 protein, but the PBoV NP1 C-terminal region does not. PBoV NP1 also induces NFk B activation by increasing the phosphorylation of p65, and we demonstrate that the C-terminal region (aa 168-218) is responsible for the induction of NFk B, although the cNLS region of NP1 enhances this activation. The data suggest that PBoV NP1 contains two functionally independent domains in its N-and C-terminal regions. Thus, the N-terminal region of PBoV NP1 is critical for its nuclear localization and IFN-related promoter inhibition, and the C-terminal region is critical for its induction of NFk B.
INTRODUCTION
Members of the genus Bocavirus (subfamily Parvovirinae; family Parvoviridae) are autonomously replicating, nonenveloped, ssDNA viruses that are closely associated with respiratory and enteric infections in humans and animals (Chen et al., 1986 (Chen et al., , 1988 . Bocaviruses include bovine parvovirus (BPV) (Chen et al., 1986) , canine minute virus (CMV) (Schwartz et al., 2002) and human bocavirus (HBoV) (Allander et al., 2005) . Porcine bocavirus (PBoV), a novel bocavirus, was first identified in Swedish pigs with post-weaning multisystemic wasting syndrome (PMWS) (Blomström et al., 2009; Manteufel & Truyen, 2008) . Different strains of PBoV have been identified in PMWS, respiratory, diarrhoeic or asymptomatic swine in many types of tissues, including lymph node, serum, intestine, lung, saliva and spleen (Blomström et al., 2009; Choi et al., 2014; Huang et al., 2014; McKillen et al., 2011; Zhai et al., 2010; Zhang et al., 2014; Zhou et al., 2014) . As it occurs in co-infections with porcine circovirus type 2, porcine torque teno virus, porcine reproductive and respiratory syndrome virus (PRRSV), classical swine fever virus, porcine epidemic diarrhoea virus, porcine kobuvirus and transmissible gastroenteritis virus (Cságola et al., 2012; Zhai et al., 2010; Zhang et al., 2011 Zhang et al., , 2013 , PBoV is thought to function as an immunosuppressive pathogen and a factor that triggers viral co-infection (Blomström et al., 2009; Manteufel & Truyen, 2008) . However, the pathogenesis of PBoV infection is still unclear.
As in other members of the genus Bocavirus, the genome of PBoV is only *5 kb in length, and contains three potential ORFs encoding two non-structural proteins (NS1 and NP1) and two structural proteins (VP1 and VP2) (Zeng et al., 2011) . The non-structural protein NP1 is a protein unique to the genus Bocavirus within the family Parvoviridae. It usually localizes to the nucleus (Lederman et al., 1984; Sukhu et al., 2013; Zhang et al., 2014) , and plays versatile roles in DNA replication, RNA processing, apoptosis and as an IFN antagonist (Sukhu et al., 2013; Sun et al., 2009 Sun et al., , 2013 Zhang et al., 2012) . As BPV and HBoV NP1 can rescue CMV DNA replication, as can CMV NP1 (Sun et al., 2009) , it is possible that bocavirus NP1 shares some similar functional domains with these proteins. Researchers have shown that the N-terminal region of the HBoV NP1 protein is essential for its nuclear localization and its induction of apoptosis Sun et al., 2013) The type I IFN system, including IFN expression and its signalling pathways, provides a powerful antiviral innate immune response (Kawai & Akira, 2006) . IFN production is regulated co-operatively by the transcription factors IFNregulatory factor 3 (IRF3) and NFk B (Munshi et al., 1999) , whereas IFN signalling is regulated by the transcription factor IFN-stimulated gene factor 3 (ISGF3) complex (Darnell et al., 1994) . In our previous study, we found that PBoV NP1 inhibited IFN responses induced by Sendai virus (SeV) or IFN-a, but enhanced the SeV-induced activation of NFk B (Zhang et al., 2015) . Whether PBoV NP1 contains a complex regulatory region or two independent functional regions that contribute to its dual regulatory activities is unclear. The intracellular distribution of PBoV NP1 has not yet been reported and whether the intracellular localization of NP1 contributes to its functions requires further investigation. In this study, we demonstrated that the N terminus of PBoV NP1 plays a critical role not only in its nuclear localization, but also in its suppression of the type I IFN promoter. The C-terminal region encompassing aa 168-218 and the nuclear localization of NP1 are involved in its induction of the NFKB promoter.
RESULTS

Identification of two potential nuclear localization signals (NLSs) in the PBoV NP1 protein
To confirm the intracellular distribution of PBoV NP1, we determined the localization of a GFP-tagged NP1 protein in PK-15 cells. Using fluorescence microscopy, we found that NP1 localized exclusively to the nucleus (Fig. 1a, b) , whereas the control GFP was diffusely spread throughout the whole cells (Fig. 1a, b) , indicating that PBoV NP1 localized to the nucleus as do the NP1 proteins of other bocaviruses. Proteins that distribute to the nucleus usually feature an NLS, either the classical NLS (cNLS) or the non-classical NLS (ncNLS) (Dingwall et al., 1982; Lange et al., 2007) . To detect the NLS responsible for its nuclear localization, we analysed the NP1 protein sequence using PSORT II software (http://www.psort.org/). Two putative monopartite NLSs within the region encompassing aa 52-66 in the NP1 N-terminal region were identified: cNLS1 at aa 52-58 (PRRKREE) and cNLS2 at aa 60-66 (PYR-GRKE) (Fig. 1c) . When these two potential cNLSs were compared with those of other NP1 proteins, we found that the cNLS sequences were not conserved in the genus Bocavirus, although no cNLS was predicted in BPV NP1 (Fig. 1d) , indicating that we found two novel cNLS in PBoV NP1. To identify the function of the two putative cNLSs of PBoV NP1, we fused cNLS1 or cNLS2 to the C terminus of GFP (Fig. 1e) . As shown in Fig. 1(f) , the two putative cNLSs were both sufficient to drive GFP completely into the nucleus, indicating that these two cNLSs of PBoV NP1 are functional.
N-terminal region of PBoV NP1 is required for its nuclear localization
To determine whether these newly identified cNLSs were essential for the nuclear localization of PBoV NP1, we generated a series of N-or C-terminally truncated mutants of the NP1 protein tagged with GFP (Fig. 2a, b) . PK-15 cells were transfected with plasmids encoding each of these GFP-tagged mutants, designated GFP-NP1-1-51+67-218 (containing aa 1-51 and 67-218), GFP-NP1-1-66, GFP-NP1-1-51, GFP-NP1-67-218 and GFP-NP1-52-218, and observed by fluorescence microscopy. As shown in Fig. 2(c) , the mutant GFP-NP1-1-51+67-218 (NP1 without the cNLS region) mainly localized to the nucleus, but was also partially distributed in the cytoplasm, indicating that NP1 contains a less-active ncNLS in addition to these cNLSs. The two C-terminal truncated mutants both localized to the nucleus (Fig. 2c) . The construct GFP-NP1-1-66 (C-terminal truncated mutant with the cNLS region) predominantly localized to the nucleus, whereas the distribution of the GFP-NP1-1-51 mutant (C-terminal truncated mutant without the cNLS region) was consistent with the GFP-NP1-1-51+67-218 mutant, suggesting that the N-terminal 51 aa region contains an active ncNLS. In contrast, the N-terminal truncations GFP-NP1-52-218 and GFP-NP1-67-218 (N-terminal truncated mutants without the cNLS region) differed in their intracellular distribution (Fig. 2c) . Mutant GFP-NP1-52-218 predominantly localized to the nucleus, whereas GFP-NP1-67-218 localized to the cytoplasm (Fig. 2c) , indicating that the cNLS region functioned for the NP1 protein, but no NLS existed in the NP1 region encompassing aa 67-218. In addition, the GFP-tagged PRRSV NSP4, which is a known cytoplasm protein, was included as a non-nuclear protein control and mainly diffused in cytoplasm too (Fig. 2c) . These results demonstrated that PBoV NP1 contained an active ncNLS in the N-terminal region at aa 1-51 and two functional cNLSs in the region defined by aa 52-66.
N-terminal region of PBoV NP1 correlates with the inhibition of IFNB promoter activity and IFN-stimulated response element (ISRE) activity
In our previous study, we found that PBoV NP1 plays a role as an antagonist of type I IFN by inhibiting IFNB promoter activity and ISRE activity (Zhang et al., 2015) . To map the region of NP1 responsible for this inhibition of IFN, HEK-293T cells were co-transfected with plasmids expressing NP1 or NP1 mutants, pRL-TK (internal control plasmid) and p125-Luc (IFN-b-Luc) or pISRE-Luc. Empty expression vectors were used as the controls. At 24 h post-transfection, the cells were infected with SeV for 16 h or treated with IFN-a for 6 h. IFN-b-Luc or ISRE-Luc was measured in the whole-cell extracts with a dual-luciferase reporter assay. As shown in Fig. 3 (a, b), similar to WT NP1, the C-terminal truncated mutants all suppressed the IFNB promoter activity and ISRE activity, whereas the N-terminal truncated mutants did not, indicating that the N terminus was required for the inhibition of IFN.
As the promoter activities of IFN-b and ISRE are mainly regulated by IRF3 and ISGF3 (Darnell et al., 1994;  Two functional regions in PBoV NP1 protein Munshi et al., 1999) , we investigated whether the N-terminal region of PBoV NP1 prevented the IFN response by targeting the IRF3-and ISGF3-mediated pathways. HEK-293T cells were co-transfected with plasmids expressing IRF3, ISGF3c-P48 (IRF9), NP1 or NP1 mutants, IFNb-Luc or ISRE-Luc and pRL-TK. The NP1 C-terminal truncated mutants inhibited the IRF3-and IRF9-induced IFN response, whereas the N-terminal truncated mutants did not (Fig. 3c, d ), indicating that the NP1 N-terminal region negatively regulates the promoter activity of IFN-b and ISRE by targeting at or downstream of IRF3 and IRF9. These results showed that the N-terminal region of PBoV NP1 contributed to its IFN inhibition.
NP1 induces NFk B activation via its C-terminal region
NFk B is an inducible transcription factor involved in the expression of type I IFN, the cytokine-induced immune response, the inflammatory response, etc. (Caamaño & Hunter, 2002; Christman et al., 2000; Li & Verma, 2002) . In this study, we found that PBoV NP1 enhanced the SeV-induced activation of the NFKB1 promoter (data not shown). Therefore, we investigated whether NP1 induced NFk B activation. HEK-293T cells were co-transfected with the NFk B-Luc luciferase reporter plasmid containing the NFk B-responsive sequence from the IFNB promoter and pCAGGS-HA-NP1, together with the internal control plasmid pRL-TK. Some transfected cells were treated with TNF-a as a positive control. As shown in Fig. 4 (a), TNF-a and NP1 notably upregulated NFKB1 promoter activity, indicating that PBoV NP1 induced the activation of the NFKB1 promoter. Further study showed that NP1 enhanced the expression of pro-inflammatory cytokines RANTES, IL-6, IL-8 and TNF-a (Fig. 4b) . Consistent with these observations, p65 phosphorylation and IkBa degradation were clearly induced by TNF-a and NP1, GFP-NP1-1-51 Two functional regions in PBoV NP1 protein whilst p65 expression remained steady in the presence of NP1 (Fig. 4c) . These data demonstrated that NP1 promoted pro-inflammatory cytokine expression by activating NFk B. To identify the functional region that correlated with this induction of NFk B, the N-and C-terminal truncations were screened with a dual-luciferase reporter assay (Fig. 4d) . The C-terminal truncated mutants of PBoV NP1 did not activate NFk B, whereas the N-terminal truncated mutants still retained this function, indicating that the C terminus of NP1 was necessary for the induction of NFk B. Interestingly, we noted that the nuclear localization of the mutant GFP-NP1-52-218 induced 12-fold greater NFKB promoter activity than the negative control, whereas the cytoplasmically localized mutant GFP-NP1-67-218 induced only a threefold increase in NFk B activity, indicating that the nuclear localization of NP1 allowed it to induce NFk B more efficiently.
To map the region of NP1 crucial for NFk B induction, we constructed three sequential C-terminal truncations, GFP-NP1-1-198, GFP-NP1-1-168 and GFP-NP1-1-108 (Fig. 4e) , and tested their ability to induce NFk B (Fig. 4f) . In contrast to the WT PBoV NP1, the ability of mutant GFP-NP1-1-198 to induce NFk B was partly impaired, whereas mutants GFP-NP1-1-168 and GFP-NP1-1-108 completely lost this ability. The data suggested that NP1 upregulated NFk B production through the region encompassing aa 68-218 in its C-terminal region and the nuclear localization of NP1 contributed to its capacity to induce NFk B. In summary, the N-terminal aa 1-66 region of PBoV NP1 correlated with its nuclear localization and its inhibition of IFN, whereas its C-terminal region contributed to its induction of NFk B.
DISCUSSION
In this study, we found that PBoV NP1 localizes to the nucleus because it contains two cNLSs and an ncNLS within its N-terminal region. Luciferase assays showed that the NP1 N-terminal region is also necessary for its IFN-antagonist activity. Our data show that NP1 induces NFk B activation through its C-terminal region. Overall, these results suggest that two functionally different regions within the PBoV NP1 N-and C-terminal regions are responsible for its nuclear localization and its regulation of IFN and NFk B.
Similar to other bocaviruses (Chen et al., 2010; Lederman et al., 1984; Sukhu et al., 2013) , we found that PBoV NP1 localizes to the nucleus. The nuclear importation of many viral proteins is typically mediated by NLSs, recognized by an adaptor protein and transported into the nucleus through the nuclear pore complex (Lange et al., 2007; Macara, 2001) . Several NLS regions have previously been identified in parvoviruses (Boisvert et al., 2014; Grieger et al., 2006; Hoque et al., 1999; Pillet et al., 2003) . Among the bocavirus NP1s, a bipartite cNLS and an ncNLS were first identified in the HBoV NP1 N-terminal region . In this study, we found two novel monopartite NLSs and an ncNLS within the N-terminal region of PBoV NP1. Consistent with this, the N-terminal regions of the bocavirus NP1s are all arginine-rich domains, suggesting that this region is functionally conserved to ensure bocavirus NP1 nuclear localization. However, the alignment of the cNLSs shows that the cNLS sequences are not conserved in bocavirus NP1 (Fig. 1d) . In contrast, our data demonstrate that the cNLSs (NLS1 and NLS2) and constructs containing the cNLS (GFP-NP1, GFP-NP1-1-66 and GFP-NP1-52-218) strongly transported GFP into the nucleus, whereas mutants containing only the ncNLS (GFP-NP1-1-51+67-218 and GFP-NP1-1-51) mainly localized in the nucleus, although they were partially distributed in the cytoplasm. This suggests that the cNLSs are more effective in nuclear import than the ncNLS. A similar phenomenon has been identified in HBoV NP1 , in which an N-terminal mutant (containing aa 7-13 and 29-50), containing only the ncNLS, only partially distributed to the nucleus. A previous study suggested that proteins with a molecular mass v60 kDa can diffuse freely into the nucleus (Wang & Brattain, 2007) . In our study, the fusion protein GFP-NP1-67-218 (*48 kDa) and GFP-NSP4 (*48 kDa) mainly located in cytoplasm, but with occasional diffusion in the nucleus (Fig. 2c) . We speculated that the occasional diffusion in the nucleus is due to their low molecular masses, resulting in their free diffusion into the nucleus.
IFN and the IFN-induced cellular antiviral response are powerful host-protective mechanisms against viruses. To combat this antiviral effect, many viruses encode proteins that function as IFN antagonists in the nucleus. For instance, the measles virus C protein inhibits the induction of IFN in the nucleus, but not in the cytoplasm (Sparrer et al., 2012) . The nuclear localization of Nipah virus W protein is required for its inhibition of dsRNA/Toll-like receptor 3 signalling (Shaw et al., 2005) . Among the bocavirus nuclear proteins, HBoV NP1 inhibits type I IFN production by blocking the IRF3 DNA-binding step (Zhang et al., 2012) and PBoV NP1 suppresses type I IFN signalling by blocking the ISGF3 DNA-binding step (Zhang et al., 2015) . Consistent with this, we found that PBoV NP1 downregulates IFNB promoter activity and ISRE activity, whilst the N-terminal region at aa 1-51 is critical for this suppression by targeting the IRF3-and ISGF3-mediated pathways. As this N-terminal region of bocavirus NP1 is necessary for its nuclear localization, and IRF3 and ISGF3 combine with the promoter in the nucleus, it is possible that the nuclear localization of bocavirus NP1 plays an important role in the regulation of IFN expression. However, we could not confirm this hypothesis because we lack exact information on the ncNLS sequence. Although the amino acid sequence in the NP1 N-terminal region is not conserved in bocaviruses, the common feature of a serine-and arginine-rich sequence in the N-terminal region may explain the similar inhibition of IFN expression by the NP1 proteins of HBoV and PBoV. In addition, we found that the mutant NP1-52-218 significantly increased the activity of the IFNB promoter (IFN-b-Luc) induced by IRF3 (Fig. 3c) . Furthermore, we found that NP1-52-218 also induced NFk B activation (NFk B-Luc) (Fig. 4d) . These observations suggest that the N-terminal truncated mutant NP1-52-218 is an IFN inducer, although the mechanism remains unclear.
NFk B is a critical transcription factor regulating the transcription of pro-inflammatory molecules that induce inflammation (Christman et al., 2000) and is also involved in the regulation of IFN production (Munshi et al., 1999) . For optimal survival, some IFN-antagonistic viruses induce the activation of NFk B to facilitate the inflammatory response and the production of immunosuppressive cytokines. For example, PRRSV, a known inhibitor of IFN production that targets the RIG-I (retinoic acid-inducible gene 1) pathway (Luo et al., 2008) , has been shown to activate NFk B to induce the production of pro-inflammatory cytokines (IL-6, IL-8 and TNF-a) (Lee & Kleiboeker, 2005; Yoo et al., 2010) and the immunosuppressive cytokine IL-10 ( Song et al., 2013) . In this study, we observed that PBoV NP1 induced the activation of NFk B by enhancing phosphorylation of p65 and degradation of IkBa. Furthermore, PBoV NP1 also promoted pro-inflammatory cytokine expression. These observations have not been previously reported in bocaviruses. Using a series of mutants, we found that the C-terminal region (aa 168-218) of the NP1 protein is essential for its activation of NFk B. As BPV and HBoV NP1 can partly replace CMV NP1 in DNA replication (Sun et al., 2009 ) and the C-terminal aa 168-218 of NP1 are highly conserved in bocaviruses, we postulate that NFk B activation by NP1 is a common function in the genus Bocavirus. The deletion of the cNLS region impaired the induction of NFk B by the PBoV NP1 C-terminal region, suggesting that nuclear NP1 more efficiently activates NFk B than NP1 distributed in the cytoplasm.
In summary, we identified two novel monopartite NLSs of PBoV NP1 within the region defined by aa 52-66 and an ncNLS within the region defined by aa 1-51. We also found two functionally independent regions in the N-terminal region (defined by aa 1-51) and the C-terminal region (defined by aa 168-218), which are responsible for the inhibition of the IFN promoter and the induction of NFk B, respectively. We could not demonstrate the effects of these regions on viral replication or immune evasion because we lacked an infectious clone of PBoV, but it will be interesting to identify the two independent functional domains of PBoV NP1. These may be helpful in illuminating the common features of the nuclear localization and immunoregulatory mechanisms of bocavirus NP1.
METHODS
Cells and viruses. PK-15 cells and HEK-293T cells were cultured and maintained in Dulbecco's modified Eagle's medium (Invitrogen) supplemented with 10% heat-inactivated FBS at 37 uC in a humidified 5% CO 2 incubator. SeV was obtained from the Center of Virus Resource and Information, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China.
Plasmids. The luciferase reporter plasmids p125-Luc (encoding IFNb-Luc), 4|PRDIII/I-Luc (encoding IRF3-Luc), 4|PRDII-Luc (encoding NFk B-Luc) and pISRE-Luc (encoding ISRE-Luc) have been described previously (Zhong et al., 2013) . The internal control plasmid pRL-TK was purchased from Promega. The generation of the DNA expression construct encoding IRF3 has been described previously . The full-length cDNA of IRF9 (GenBank accession number NM_006084) was amplified from total RNA extracted from HEK-293T cells and cloned into the pCMV-Tag2B expression vector to generate pCMV-IRF9.
The coding sequence of the full-length PBoV NP1 protein was amplified by PCR from the almost full-length cDNA sequence of bocavirus pig/SX/China/2010 (GenBank accession number HQ223038), and was inserted into the expression vectors pEGFP-C1 (Clontech) and pCAGGS-HA. The cDNA fragment encoding NSP4 of PRRSV strain WUH3 was amplified by PCR from PRRSV-infected Marc-145 cells and cloned into vector pEGFP-C1 (Clontech). The mutant fragments of NP1 were generated with appropriately designed primers and subcloned into the pEGFP-C1 vector. The oligonucleotides encoding cNLS1 ( 52 PRRKREE 58 ) and cNLS2 ( 60 PYRGRKE 66 ) were inserted into pEGFP-C1 to create pEGFP-C1-cNLS1 and pEGFP-C1-cNLS2, respectively. All the primers used for the construction of these plasmids are listed in Table 1 .
Transfection and luciferase reporter assay. HEK-293T cells were transfected using Lipofectamine 2000 (Invitrogen), according to the manufacturer's instructions. For the luciferase reporter assays, HEK-293T cells grown in 24-well plates were co-transfected with reporter plasmid (IFN-b-Luc, IRF3-Luc or NFk B-Luc) at 0.1 mg per well together with pRL-TK plasmid and various other expression plasmids or the empty control plasmid at 0.05 mg per well. At 24 h post-transfection, the cells were further stimulated with SeV for 16 h. The luciferase activity was determined with a Dual-Luciferase Reporter Assay System (Promega), according to the manufacturer's protocol. In some experiments, HEK-293T cells in 24-well plates were co-transfected with reporter plasmid pISRE-Luc at 0.1 mg per well and internal control plasmid pRL-TK at 0.05 mg per well. At 24 h after the initial co-transfection, the cells were further stimulated with IFN-a for 6 h. The data represent the relative firefly luciferase activity normalized to the Renilla luciferase activity and are representative of three independent experiments. SYBR Green PCR assay (Applied Biosystems). The abundance of the individual mRNA transcripts in each sample was assayed three times and normalized to that of glyceraldehyde 3-phosphate dehydrogenase mRNA (the internal control).
Fluorescence assay. For the confocal microscopy analysis, PK-15 cells were grown on coverslips and then transfected with GFP-fused constructs. At 24 h post-transfection, the cells were fixed with 4% paraformaldehyde for 10 min and then permeabilized with 0.1% Triton X-100 for 10 min at room temperature. After three washes with PBS, the cells were incubated with DAPI for 5 min at room temperature. After the cells were washed with PBS, fluorescent images were captured with a confocal laser scanning microscope (LSM 510 Meta; Carl Zeiss MicroImaging).
Immunoblotting assays. Briefly, HEK-293T cells cultured in 60 mm dishes were transfected with the appropriate plasmids. After 28 h, the cells were harvested by the addition of 150 ml lysis buffer (4% SDS, 3% DTT, 0.065 mM Tris/HCl, pH 6.8, 30% glycerine) and the protein concentrations in the whole-cell extracts were measured. Equal amounts of the samples were then subjected to SDS-PAGE, and analysed for the expression of p65, phosphorylated p65 and Ik Ba proteins with immunoblotting using rabbit anti-p65, anti-p65 p-Ser536 and anti-Ik Ba antibodies (Cell Signaling Technology), respectively. To confirm the expression levels of GFP-tagged PBoV NP1 and its mutant proteins, an anti-GFP antibody (MBL) was used for immunoblotting. The expression of b-actin was detected with a mouse anti-b-actin mAb (MBL) to demonstrate equal protein sample loading.
Statistical analysis. All experiments were performed at least three times with reproducible results. Data are presented as mean+SD. Statistical analysis was performed using one-way ANOVA without interaction terms followed by Dunnett's test for multiple comparisons. Pv0.05 was considered statistically significant. Primer Sequence HA-NP1-F CCGCTCGAGATGAGTGGGCATCACAGCCAC HA-NP1-R CCGGAATTCTTATTTTCCAGCTTCAGCTTC EGFP-NP1-F CCGCTCGAGCTATGAGTGGGCATCACAGC EGFP-NP1-R CCGGAATTCTTATTTTCCAGCTTCAGCTT EGFP-NP1-52-218-F CCGCTCGAGCTATGCCAAGAAGAAAGAGG EGFP-NP1-67-218-F CCGCTCGAGCTATGATGAGCAGATCTCCC EGFP-NP1-1-51-R CCGGAATTCTTATTCTTTCCTCCCCC EGFP-NP1-1-67-R CCGGAATTCTTAACTCCGACTCCGAC EGFP-NP1-1-51+67-218-N-R GGGAGATCTGCTCATGCTACTCCGACTCCGACTCCAACTCCG EGFP-NP1-1-51+67-218-C-F AGTCGGAGTCGGAGTAGCATGAGCAGATCTCCCAGAAACAGG EGFP-NP1-1-198-R CCGGAATTCTTAAGGTTCATGATGCA EGFP-NP1-1-168-R CCGGAATTCTTACATGCTTCTGTAA EGFP-NP1-1-108-R CCGGAATTCTTATTGATCAGTATTATG NLS1-F TCGAGCTCCAAAAAGAAAGAGGGAGGAGG NLS1-R AATTCCTCCTCCCTCTTTCTTTTTGGAGC NLS2-F TCGAGCTCCAAGAAGAAAGAGGGAGGAGG NLS2-R AATTCCTCCTCCCTCTTTCTTCTTGGAGC Flag-IRF-9-F CCGGAATTCATGGCATCAGGCAGGGCAC Flag-IRF-9-R CCCTCGAGCTACACCAGGGACAGAATGG
